Avita Medical
RCEL
67 hedge funds and large institutions have $16.6M invested in Avita Medical in 2025 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 29 reducing their positions, and 17 closing their positions.
527% more call options, than puts
Call options by funds: $464K | Put options by funds: $74K
3.49% less ownership
Funds ownership: 19.3% → 15.82% (-3.5%)
12% less funds holding
Funds holding: 76 → 67 (-9)
37% less capital invested
Capital invested by funds: $26.3M → $16.6M (-$9.62M)
52% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 29
53% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$589K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$316K |
| 3 |
Morgan Stanley
New York
|
+$209K |
| 4 |
JG
Jain Global
New York
|
+$96.4K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$80.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$475K |
| 2 |
Millennium Management
New York
|
-$376K |
| 3 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$301K |
| 4 |
Jane Street
New York
|
-$236K |
| 5 |
BlackRock
New York
|
-$234K |
RCEL Hedge Fund Activity: Q4 2025 in Review
67 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q4 2025, worth a combined $16.6M — down 37% from $26.3M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of RCEL and 8 opened new positions — a net loss of 9 holders — while 29 trimmed existing stakes and 14 added.
The largest buyer was Geode Capital Management, adding an estimated $589K. The largest seller was HRT Financial, exiting entirely with an estimated $475K sold.
- 67 institutional investors held Avita Medical (RCEL) as of Q4 2025, down from 76 in Q3 2025.
- Funds reported $16.6M of Avita Medical stock for Q4 2025, down 37% quarter-over-quarter.
- 8 funds opened new Avita Medical positions in Q4 2025 and 17 closed out, a net change of -9 holders.
- The largest Avita Medical buyer in Q4 2025 was Geode Capital Management, an estimated $589K added.
- The largest Avita Medical seller in Q4 2025 was HRT Financial, an estimated $475K sold.
Based on aggregated 13F filings for Q4 2025.